View PDF Version - RePub - Erasmus Universiteit Rotterdam

(1988) SV40 large tumor antigen forms a spedne complex with the product of the retinoblastoma susceptibility
gene. Cell 54:275-283.
DeCaprio JA, Ludlow JW, Lynch 0, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM, Livingston DM
(1989) The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element.
Cell 58: 1085-1095.
Delattre 0, Azambuja CJ, Aurias A, Zucman J, Peter M, Zhang F. Hors-Cayla MC et aJ. (1991) Mapping of
human chromosome 22 with a panel of somatic cell hybrids. Genomics 9:721-727.
Devilee P, van Vliet M, Kuipers-Dijkshoorn N, Pearson PL, Comelisse CJ (199Ia) Somatic genetic changes
on chromosome 18 in breast carcinomas: is the DCC gene involved? Oncogene 6:311-315.
Devilee P, van den Broek M, Mannens M. Slater R. Cornelisse CJ, Westerveld A. Meera Khan P (l99Ib)
Differences in patterns of aUelic loss between two common types of adult cancer, breast and colon carcinoma
and Wilms' tumor of childhood. Int J Cancer 47:817-821.
Dittmer D, Pati S, Zambelli G, Chu S, Teresky AK, Moore M, Finlay C, Levine A1 (1993) Gain of function
mutations in p53. Nature Genet 4:42-46.
Domenicucci M. Santoro A, D'Osvaldo DH, Delfllli R, Cantore GP, Guidetti B (1989) Multiple intracranial
meningiomas. J Neurosurg 70:41-44.
Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, RUlel JS, Bradley A (1992) Mice
deficient for pS3 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221.
Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K. Lairmore Te, Howe JR et a!. (1993) Mutations in
the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2: 851-856.
Drummond lA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhame VP, Rauscher FJ (1992) Repression of the
insulin-like growth factor II gene by the Wilms tumor suppressor WTI. Science 257:674-677.
Dumanski JP, Rouleau GA, NordenskjOJd M. Collins P (1990a) Molecular genetic analysis of chromosome 22
in 81 cases of meningioma. Cancer Res 50:5863-5867.
Dumanski JP, Geurts van Kessel AHM, Ruttledge M, Wladis A, Sugawa N, Collins VP, NordenskjOld M
(l990b) Isolation of anonymous polymorphic DNA fragments from human chromosome 22q 12-qter. Hum Genet
84:219·222.
Dumanski JP, earlbom E, Collins VP, NordenskjOid M, Emanuel BS, BudarfML, McDermid H et al. (1991)
A map of 22 loci on human chromosome 22. Genomics 11:709-719.
Dyson N, Howley PM, Munger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein ia able to
bind to the retinoblastoma gene product. Science 243:934-937.
Edery P, Lyonnet S, Mulligan LM. Pelel A, Dow E, Abel L, Holder S, Nihoul-F~kt~te C el al. (1994)
Mutations of the RET proto-oncogene in Hirschprung's disease. Nature 367:378-380.
EI-Deiry WS, Kern SE, Pieterpol JA, Kinzler KW, Vogelstein B. (1992) Definition of a consensus binding site
for p53. Nature Genet 1 :45-49.
EI-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D et a!. (1993) WAFI, a
potential mediator of pS3 tumor suppression. Cell 75:817-825.
Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi D, Oren M (1989) Wild-type pS3 can inhibit oncogenemediated
focus formation. Proc Natl Acad Sci USA 86:8763-8767.
Emanuel BS, Budarf ML, Seizinger BR (l991) Report of the committee on the genetic constitution of
chromosome 22. Cytogenet Cell Genet 58: 827~852.
Emanuel BS, Buetow K, Nussbaum R, Scambler P, Lipinski M, OVerton GC (1993) Third international
workshop on human chromosome 22 mapping 1992. Cytogenet Cell Genet 63:205-211.
Evans DGR, Huson SM, Donnai 0, Neary W, Blair V, Newlon V, Harris R (l992a) A clinical study of type
2 neurofibromatosis. Quart J Med 304:603-618.
Evans DGR, Huson SM, Donnai 0, Neary W, Blair V, Teare 0, Newton V et al. (1992b) A genetic study of
type. 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness and confinnation of
maternal transmission effect on severity. J Moo Genet 29:841-846.
I
43